| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4c6a2eb66d07fad39d708e5a36c9350 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9995e0af1a570ea98e08de4b90cc43ae |
| publicationDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9150660-B1 |
| titleOfInvention |
Precision Medicine by targeting human NAV1.8 variants for treatment of pain |
| abstract |
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920123-B2 |
| priorityDate |
2014-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |